Xarelto Trial Dates Set in Early 2017
Four trial dates are set for early 2017 for the consolidated multidistrict litigation (MDL) against Bayer AG and a Johnson and Johnson subsidiary regarding injuries sustained by Xarelto patients. U.S. District Judge Eldon Fallon in the Eastern District of Louisiana issued the order for trial dates of February 6, 2017 and March 13, 2017. Mississippi’s Xarelto trials will be held on April 24, 2017. In Texas, the Xarelto trial will occur on May 30, 2017. The MDL allows the large number of individual cases of Xarelto injuries to benefit from certain streamlined class action processes, without becoming a class, including pre-trial motions, discovery, and settlement conferences. All plaintiffs will reap the benefits of all of the available evidence. The consolidated lawsuits allege that Xarelto causes severe internal bleeding, serious injuries, and death.